Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Prices of 851...

    Prices of 851 essential drug formulations cut in past 2 year: Government

    Written by Ruby Khatun Khatun Published On 2018-03-15T10:00:55+05:30  |  Updated On 15 March 2018 10:00 AM IST
    Prices of 851 essential drug formulations cut in past 2 year: Government

    New Delhi: Prices of 851 essential drug formulations were cut, mostly in the 5-40 percent range, in the past 2 years, the government said.


    In a written reply to the Lok Sabha, Minister of State for Chemicals and Fertilisers Mansukh L Mandaviya said the government has cut the prices of 234 essential drugs by up to 5 percent.


    Prices of another 134 formulations were reduced in the range of 5-10 percent, and of more 98 products by 10-15 percent.


    Another set of 98 formulations saw prices reduced by 15-20 percent. In addition to that 93 formulations saw prices drop by 20-25 percent, the minister said.


    He further said that NPPA (National Pharmaceutical Pricing Authority) also slashed prices of 65 products ranging between 25-30 percent, 46 products between 30-35 percent, 24 products in the range of 35-40 per and 59 products over 40 percent.


    In a separate reply, Mandaviya said turnover of scheduled formulations stood at Rs 19,877 crore for the year ended December 31.


    The growth rate for such formulations declined by 3 percent last year as compared with a growth of 2 percent in 2016 and 13 percent in 2015, the minister said.


    In same time turnover of non-scheduled formulations stood at Rs 96,512 crore last year, a growth of 8 percent, he added.


    The total turnover of both scheduled and non-scheduled formulations stood at Rs 1,16,389 crore, a growth of 6 percent, the minister said.

    cutcut pricesessential drug formulationsessential drugsformulationsgovernmentLok SabhaMansukh L MandaviyaMinister of State for Chemicals and FertilisersNational Pharmaceutical Pricing AuthorityNPPApricesScheduled formulations
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok